Parecer de pré-exame
#6.23
09/19/2023
RPI 2750
Application data
Number
112021008087Type
Filing
Publication
PCT
US2019052705 The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.
Latest action published by the INPI: 09/19/2023. We update with every new RPI gazette, published weekly.
Applicants
C. C. (pessoa física)
US
Inventors
K. C. (pessoa física)
US
T. C. (pessoa física)
US
IPC Classification
Priority claims
US
62/735,997 · 09/25/2018
US
62/785,602 · 12/27/2018
US
62/785,605 · 12/27/2018
US
62/785,606 · 12/27/2018
US
62/787,614 · 01/02/2019
US
62/817,274 · 03/12/2019
US
62/840,539 · 04/30/2019
Abstract
A presente invenção refere-se a uma combinação farmacêutica que compreende um inibidor de efeitos adversos do agonista de dopamina e um agonista de dopamina, para o tratamento da doença de Parkinson e distúrbios relacionados à doença de Parkinson.
Publications in the Brazilian Industrial Property Gazette (RPI).
#6.23
09/19/2023
RPI 2750
08/15/2023
RPI 2745
#8.6
Referente à 4ª anuidade.
07/18/2023
RPI 2741
#1.3
08/03/2021
RPI 2639
#1.1
05/11/2021
RPI 2627
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.